Aerocrine AB (AERO B) - Strategic SWOT Analysis Review

Date: July 28, 2015
Pages: 41
Price:
US$ 125.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: A9E2DD88DC4EN
Leaflet:

Download PDF Leaflet

Aerocrine AB (AERO B) - Strategic SWOT Analysis Review
Aerocrine AB (AERO B) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – GlobalData’s summarization of the company’s business strategy.
  • SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
Highlights

Aerocrine AB (Aerocrine), a subsidiary of Circassia Pharmaceuticals Plc is a medical products company. It markets and sells medical devices and tests. The company offers its products for diagnosis, treatment and monitoring of patients suffering from inflammation of airways. The company offers nitric oxide (NO) monitoring devices. The company products find application in the areas of diagnosis, treatment and control of inflammation of the airways and clinical applications. The company offers these products to hospitals, research clinics, and healthcare units. The company distributes its products through subsidiaries in the US, Germany, and through distributors in Japan, Canada, Poland, Portugal, Spain, Australia, and South America, among others. Aerocrine is headquartered in Solna, Sweden.

Aerocrine AB Key Recent Developments

Jul 13, 2015: Aerocrine is delisted today
Jun 26, 2015: Aerocrine applies for delisting
May 12, 2015: Aerocrine Sales Grow to Record Levels Again for 1st Quarter, NIOX VERO Launch in the US Off to A Strong Start
Apr 16, 2015: Changes in Aerocrine’s Executive Leadership Team
Feb 20, 2015: Aerocrine Achieves Record Sales for the 4th Quarter and Full Year

Reasons to Buy
  • Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
  • Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
  • Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
  • Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Note: Some sections may be missing if data is unavailable for the company.
SECTION 1 - ABOUT THE COMPANY

Aerocrine AB - Key Facts
Aerocrine AB - Key Employees
Aerocrine AB - Key Employee Biographies
Aerocrine AB - Major Products and Services
Aerocrine AB - Medical Equipment Pipeline Products Data
Aerocrine AB Pipeline Products by Equipment Type
Aerocrine AB Pipeline Products by Development Stage
Aerocrine AB - History
Aerocrine AB - Company Statement
Aerocrine AB - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Aerocrine AB - Business Description
Aerocrine AB - Corporate Strategy
Aerocrine AB - SWOT Analysis
SWOT Analysis - Overview
Aerocrine AB - Strengths
Strength - Research and Development
Strength - NIOX MINO Technology
Strength - Strong Presence in the North America/ US market
Aerocrine AB - Weaknesses
Weakness - History of Losses
Weakness - Rising Debt Burden
Weakness - Declining Cash Reserves
Aerocrine AB - Opportunities
Opportunity - Market Opportunity: Asthma
Opportunity - Product Approvals
Opportunity - Positive Outlook of Medical Device Industry
Aerocrine AB - Threats
Threat - Competitive Landscape
Threat - Government Regulations
Threat - Rapid Technological Change
Aerocrine AB - Key Competitors

SECTION 3 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Aerocrine AB, Medical Equipment, Deals By Year, 2009 to YTD 2015
Aerocrine AB, Medical Equipment, Deals By Type, 2009 to YTD 2015
Aerocrine AB, Recent Deals Summary

SECTION 4 – COMPANY’S RECENT DEVELOPMENTS

Jul 13, 2015: Aerocrine is delisted today
Jun 26, 2015: Aerocrine applies for delisting
May 12, 2015: Aerocrine Sales Grow to Record Levels Again for 1st Quarter, NIOX VERO Launch in the US Off to A Strong Start
Apr 22, 2015: Aerocrine: Sales start of NIOX VERO in Japan
Apr 16, 2015: Changes in Aerocrine’s Executive Leadership Team
Mar 06, 2015: Aerocrine Receives FDA Clearance for NIOX VERO BlueTooth Wireless Enhancement
Feb 20, 2015: Aerocrine Achieves Record Sales for the 4th Quarter and Full Year
Jan 29, 2015: Aerocrine Receives Japanese Health Authority Clearance For NIOX VERO
Jan 07, 2015: Aerocrine Reports Record Sales for the 4th Quarter and Full Year 2014
Dec 15, 2014: Aerocrine resumes sales and marketing of NIOX MINO in China after re-registration approval

SECTION 5 – APPENDIX

Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Aerocrine AB, Key Facts
Aerocrine AB, Key Employees
Aerocrine AB, Key Employee Biographies
Aerocrine AB, Major Products and Services
Aerocrine AB Number of Pipeline Products by Equipment Type
Aerocrine AB Pipeline Products by Equipment Type
Aerocrine AB Number of Pipeline Products by Development Stage
Aerocrine AB Pipeline Products by Development Stage
Aerocrine AB, History
Aerocrine AB, Subsidiaries
Aerocrine AB, Key Competitors
Aerocrine AB, Medical Equipment, Deals By Year, 2009 to YTD 2015
Aerocrine AB, Medical Equipment, Deals By Type, 2009 to YTD 2015
Aerocrine AB, Recent Deals Summary

LIST OF FIGURES

Aerocrine AB Pipeline Products by Equipment Type
Aerocrine AB Pipeline Products by Development Stage
Aerocrine AB, Medical Equipment, Deals By Year, 2009 to YTD 2015
Aerocrine AB, Medical Equipment, Deals by Type, 2009 to YTD 2015
Skip to top


Ask Your Question

Aerocrine AB (AERO B) - Strategic SWOT Analysis Review
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: